206
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Crocin as a novel therapeutic agent against colitis

, , , , , , , , , , , & show all
Pages 514-521 | Received 02 Jul 2018, Accepted 19 Sep 2018, Published online: 03 Feb 2019

References

  • Adalier, N., Parker, H., and Vitamin, E., 2016. Turmeric and saffron in treatment of Alzheimer’s disease. Antioxidants, 5 (4), 40.
  • Aebi, H., 1984. Catalase in vitro. Methods in Enzymology, 105, 121–126.
  • Aggarwal, A., Sabol, T., and Vaziri, H., 2017. Update on the use of biologic therapy in ulcerative colitis. Current Treatment Options in Gastroenterology, 15 (1), 1–13.
  • Alavizadeh, S.H. and Hosseinzadeh, H., 2014. Bioactivity assessment and toxicity of crocin: a comprehensive review. Food and Chemical Toxicology, 64, 65–80.
  • Ali, A.A., et al., 2016. Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats. Pharmacological Reports, 69 (2), 268–275.
  • Amerizadeh, F., et al., 2018. Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt/PI3K pathway in a mouse model of colitis-associated colorectal cancer. J Cell Biochem. 119 (12), 10250–10261.
  • Ashrafi, M., et al., 2015. Effect of crocin on cell cycle regulators in N-nitroso-N-methylurea-induced breast cancer in rats. DNA and Cell Biology, 34 (11), 684–691.
  • Ben Salem, I., et al., 2015. Protective effect of crocin against zearalenone-induced oxidative stress in liver and kidney of Balb/c mice. Environmental Science and Pollution Research International, 22 (23), 19069–19076.
  • Bryant, R.V., Brain, O., and Travis, S.P., 2015. Conventional drug therapy for inflammatory bowel disease. Scand. J. Gastroenterol, 50 (1), 90–112.
  • Carvalho, P.B. and Cotter, J., 2017. Mucosal healing in ulcerative colitis: a comprehensive review. Drugs, 77 (2), 159–173.
  • Chen, S., et al., 2015. Crocin inhibits cell proliferation and enhances cisplatin and pemetrexed chemosensitivity in lung cancer cells. Translational Lung Cancer Research, 4 (6), 775–783.
  • Cho, D.-H. and Lim, S.-T., 2016. Germinated brown rice and its bio-functional compounds. Food Chemistry, 196, 259–271.
  • Choi, P. and Zelig, M., 1994. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut, 35 (7), 950–954.
  • Christodoulou, E., et al., 2015. Saffron: a natural product with potential pharmaceutical applications. The Journal of Pharmacy and Pharmacology, 67 (12), 1634–1649.
  • Dignass, A., et al., 2012. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. Journal of Crohn's and Colitis, 6 (10), 965–990.
  • Eaden, J., Abrams, K., and Mayberry, J., 2001. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut, 48 (4), 526–535.
  • Elmi, S., et al., 2008. Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice. Vascul Pharmacol. 48 (1), 1–8.
  • Gordon, I.O., et al., 2014. Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. Inflammatory Bowel Diseases, 20 (11), 2198–2206.
  • Grivennikov, S.I., 2013. Inflammation and colorectal cancer: colitis-associated neoplasia. Seminars in Immunopathology, 35 (2), 229–244.
  • Guo, T., et al., 2017. Octacosanol attenuates inflammation in both RAW264.7 macrophages and a mouse model of colitis. Journal of Agricultural and Food Chemistry, 65 (18), 3647–3658.
  • Hamer, H.M., et al., 2010. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clinical Nutrition, 29 (6), 738–744.
  • Hassanian, S.M., et al., 2015. Inorganic polyphosphate elicits pro-inflammatory responses through activation of the mammalian target of rapamycin complexes 1 and 2 in vascular endothelial cells. Journal of Thrombosis and Haemostasis, 13 (5), 860–871.
  • Hassanian, S.M., et al., 2016. Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR/Wnt/β-catenin signaling in endothelial cells. Journal of Thrombosis and Haemostasis, 14 (11), 2261–2273.
  • Hosseinzadeh, H., et al., 2010. Acute and sub-cute toxicity of crocin, a constituent of Crocus sativus L.(saffron), in mice and rats. Pharmacologyonline, 2, 943–995.
  • Hosseinzadeh, H., Shamsaie, F., and Mehri, S., 2009. Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus L. stigma and its bioactive constituents, crocin and safranal. Pharmacognosy Magazine, 5, 419.
  • Jess, T., Rungoe, C., and Peyrin-Biroulet, L., 2012. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 10 (6), 639–645.
  • Kawabata, K., et al., 2012. Dietary crocin inhibits colitis and colitis-associated colorectal carcinogenesis in male ICR mice. Evidence-Based Complementary and Alternative Medicine : Ecam, 2012, 820415.
  • Khorasanchi, Z., et al., 2018. Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties. Phytomedicine, 43, 21–27.
  • Lu, P., et al., 2015. Antitumor effects of crocin on human breast cancer cells. International Journal of Clinical and Experimental Medicine, 8 (11), 20316–20322.
  • Mashmoul, M., et al., 2016. Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese rats. BMC Complementary and Alternative Medicine, 16, 401.
  • Mattar, M.C., et al., 2011. Current management of inflammatory bowel disease and colorectal cancer. Gastrointestinal Cancer Research: Gcr, 4 (2), 53–61.
  • Mazidi, M., et al., 2016. A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression. Journal of Complementary; Integrative Medicine, 13 (2), 195–199.
  • Modaghegh, M.-H., et al., 2008. safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 15 (12), 1032–1037.
  • Moshiri, M., Vahabzadeh, M., and Hosseinzadeh, H., 2015. Clinical applications of saffron (Crocus sativus) and its constituents: a review. Drug Research, 65 (6), 287–295.
  • Ochiai, T., et al., 2004. Crocin prevents the death of rat pheochromyctoma (PC-12) cells by its antioxidant effects stronger than those of alpha-tocopherol. Neuroscience Letters, 362 (1), 61–64.
  • Razavi, B.M., and Hosseinzadeh, H., 2016. Saffron: a promising natural medicine in the treatment of metabolic syndrome. Journal of the Science of Food and Agriculture, 97 (6), 1679–1685.
  • Sallam, N., Khazaei, M., and Laher, I., 2010. Effect of moderate-intensity exercise on plasma C-reactive protein and aortic endothelial function in type 2 diabetic mice. Mediators Inflamm. 2010, 149678. doi: 10.1155/2010/149678. Epub 2010 Aug 2.
  • Salem, I.B., et al., 2016. Crocin, the main active saffron constituent, mitigates dichlorvos-induced oxidative stress and apoptosis in HCT-116 cells. Biomedicine & Pharmacotherapy, 82, 65–71.
  • Samarghandian, S., Boskabady, M.H., and Davoodi, S., 2010. Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line. Pharmacognosy Magazine, 6 (24), 309–314.
  • Shafiee, M., et al., 2017. Saffron against components of metabolic syndrome: current status and prospective. Journal of Agricultural and Food Chemistry, 65 (50), 10837–10843.
  • Shafiee, M., et al., 2018. Saffron in the treatment of depression, anxiety and other mental disorders: current evidence and potential mechanisms of action. Journal of Affective Disorders, 227, 330–337.
  • Sun, Y., et al., 2015. The effect and mechanisms of proliferative inhibition of crocin on human leukaemia jurkat cells. The West Indian Medical Journal, 64 (5), 473–479.
  • Taheri, F., et al., 2014. Assessment of crocin toxicity on the rat liver. Modares Journal of Medical Sciences: Pathobiology, 7, 66–108.
  • Xiao, B., et al., 2016. Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation. Theranostics, 6 (12), 2250.
  • Yavuz, Y., et al., 1999. The effect of antioxidant therapy on colonic inflammation in the rat. Research in Experimental Medicine, 199 (2), 101–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.